Free Trial
NYSE:VEEV

Veeva Systems (VEEV) Stock Price, News & Analysis

$199.18
+2.12 (+1.08%)
(As of 04:04 PM ET)
Today's Range
$196.10
$200.86
50-Day Range
$178.74
$201.30
52-Week Range
$162.72
$236.90
Volume
628,502 shs
Average Volume
954,818 shs
Market Capitalization
$32.20 billion
P/E Ratio
58.76
Dividend Yield
N/A
Price Target
$228.27

Veeva Systems MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.64 Rating Score
Upside/​Downside
14.4% Upside
$228.27 Price Target
Short Interest
Healthy
1.34% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.79
Upright™ Environmental Score
News Sentiment
0.68mentions of Veeva Systems in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$3.24 M Sold Last Quarter
Proj. Earnings Growth
11.93%
From $4.19 to $4.69 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.69 out of 5 stars

Computer And Technology Sector

57th out of 591 stocks

Prepackaged Software Industry

15th out of 196 stocks

VEEV stock logo

About Veeva Systems Stock (NYSE:VEEV)

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

VEEV Stock Price History

VEEV Stock News Headlines

“Pre-programmed” stock crash?
Time Magazine: "The Stock Market Is Rigged... So What?" Bloomberg , Business Insider , Time Magazine, and even The New York Times cannot hide the uncomfortable truth: investors are now playing a rigged game. So what do you do... give up? Absolutely not. In fact, one of America's most sought-after financial authorities (who's followed by the world's 10 richest institutional investors) just explained how you can protect yourself.
Veeva Systems (VEEV) Scheduled to Post Quarterly Earnings on Wednesday
“Pre-programmed” stock crash?
Time Magazine: "The Stock Market Is Rigged... So What?" Bloomberg , Business Insider , Time Magazine, and even The New York Times cannot hide the uncomfortable truth: investors are now playing a rigged game. So what do you do... give up? Absolutely not. In fact, one of America's most sought-after financial authorities (who's followed by the world's 10 richest institutional investors) just explained how you can protect yourself.
Catalyst Clinical Research Announces First CCO
See More Headlines
Receive VEEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/30/2024
Today
8/23/2024
Next Earnings (Confirmed)
8/28/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Computer Software
Employees
7,172
Year Founded
2007

Price Target and Rating

Average Stock Price Target
$228.27
High Stock Price Target
$270.00
Low Stock Price Target
$173.00
Potential Upside/Downside
+14.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
22 Analysts

Profitability

Net Income
$525.71 million
Pretax Margin
28.26%

Debt

Sales & Book Value

Annual Sales
$2.36 billion
Cash Flow
$3.61 per share
Book Value
$28.80 per share

Miscellaneous

Free Float
144,679,000
Market Cap
$32.19 billion
Optionable
Optionable
Beta
0.80

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Veeva Systems Inc.:

  • Veeva Systems has consistently beaten earnings estimates, indicating strong financial performance.
  • The company has a solid return on equity of 12.74%, showcasing efficient use of shareholder funds.
  • Positive analyst ratings and price target upgrades suggest confidence in the company's growth potential.
  • Cloud-based software for the life sciences industry is a growing market with high demand and potential for expansion.
  • Current stock price at $185.14 presents a potential buying opportunity for investors looking for value.

Cons

Investors should be bearish about investing in Veeva Systems Inc. for these reasons:

  • Recent trading down by 2.1% may indicate short-term volatility or market concerns affecting the stock price.
  • The company's P/E ratio of 54.61 is relatively high, suggesting the stock may be overvalued compared to industry peers.
  • Downward revisions in price targets by some analysts could signal potential challenges or uncertainties ahead.
  • Market cap of $29.93 billion may limit significant short-term growth potential for the stock.
  • Lower-than-expected revenue figures in previous quarters could impact investor sentiment and future stock performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, August 18, 2024. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com.

VEEV Stock Analysis - Frequently Asked Questions

How have VEEV shares performed this year?

Veeva Systems' stock was trading at $192.52 at the beginning of the year. Since then, VEEV shares have increased by 3.6% and is now trading at $199.47.
View the best growth stocks for 2024 here
.

How were Veeva Systems' earnings last quarter?

Veeva Systems Inc. (NYSE:VEEV) announced its earnings results on Thursday, May, 30th. The technology company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.10. The technology company had revenue of $650.35 million for the quarter, compared to analysts' expectations of $641.73 million. Veeva Systems had a trailing twelve-month return on equity of 12.74% and a net margin of 22.34%.

What is Peter Gassner's approval rating as Veeva Systems' CEO?

202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com. Peter Gassner has an approval rating of 82% among the company's employees.

Does Veeva Systems have any subsidiaries?

The following companies are subsidiaries of Veeva Systems: Veeva RTSM, Veracity Logic, Learnaboutgmp, Physicians World, Veeva Crossix, Zinc Ahead Ltd, Selligy, and AdvantageMS.

Who are Veeva Systems' major shareholders?

Veeva Systems' top institutional investors include Massachusetts Financial Services Co. MA (1.33%), Van ECK Associates Corp (1.19%), Blair William & Co. IL (0.84%) and TD Asset Management Inc (0.65%). Insiders that own company stock include Matthew J Wallach, Thomas D Schwenger, Alan Mateo, Eleni Nitsa Zuppas, Paul Edward Chamberlain, Paul J Sekhri, Jonathan Faddis, Michele O'connor, Timothy S Cabral, Mary Lynne Hedley, Ronald E F Codd and Peter P Gassner.
View institutional ownership trends
.

How do I buy shares of Veeva Systems?

Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Veeva Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Veeva Systems investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), PayPal (PYPL), Shopify (SHOP), Walt Disney (DIS) and Adobe (ADBE).

This page (NYSE:VEEV) was last updated on 8/23/2024 by MarketBeat.com Staff

From Our Partners